Cintirorgon

DB20916InvestigationalSmall molecule

Cintirorgon is a small molecule drug. Cintirorgon is under investigation in clinical trial NCT02929862 (Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer). Cintirorgon has a monoisotopic...

Formula / weight: C₂₇H₂₃F₆NO₆S · 603.53 g/mol (avg)
Code names: LYC-55716

Resolves to

Compound

UNIILPN433P0EACAS2055536-64-4ChEMBLCHEMBL4472508ChEBI757693PubChem124126348

Structure

InChIKeyGULSIMHVQYBADX-FQEVSTJZSA-NSMILESCC(C)(C[C@H]1CN(C2=C(O1)C=CC(=C2)C1=CC(OC(F)F)=CC(F)=C1)S(=O)(=O)C1=CC(=CC=C1)C(F)(F)F)C(O)=O

Targets

P51449RORC

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Cintirorgon, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account